Fusion Pharmaceuticals Correlations

Summary

FUSNDelisted Stock

USD 3.75 0.33 8.09%

The current 90-days correlation between Fusion Pharmaceuticals and Bicycle Therapeutics is -0.14 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fusion Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fusion Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Fusion Pharmaceuticals Correlation With Market

Good diversification

The correlation between Fusion Pharmaceuticals and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fusion Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Moving together with Fusion Stock

0.7	MCD	McDonalds Fiscal Year End 3rd of February 2025	Pair Corr
0.66	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr

Moving against Fusion Stock

0.33

BKRKF

PT Bank Rakyat

Pair Corr

Related Correlations Analysis

	BCYC	RLMD	RAPT	NAMS	BCAB	PASG	PMVP	IKNA	OLMA	SPRO
BCYC		0.61	0.27	-0.16	0.37	0.2	-0.14	0.01	0.64	0.3	BCYC
RLMD	0.61		0.1	0.04	0.43	-0.25	0.05	-0.06	0.42	-0.06	RLMD
RAPT	0.27	0.1		-0.17	0.64	0.44	0.2	0.21	0.67	0.67	RAPT
NAMS	-0.16	0.04	-0.17		0.16	-0.56	0.68	0.2	-0.48	-0.48	NAMS
BCAB	0.37	0.43	0.64	0.16		0.03	0.31	0.13	0.44	0.25	BCAB
PASG	0.2	-0.25	0.44	-0.56	0.03		-0.24	0.11	0.56	0.71	PASG
PMVP	-0.14	0.05	0.2	0.68	0.31	-0.24		0.32	-0.18	-0.08	PMVP
IKNA	0.01	-0.06	0.21	0.2	0.13	0.11	0.32		-0.01	0.14	IKNA
OLMA	0.64	0.42	0.67	-0.48	0.44	0.56	-0.18	-0.01		0.73	OLMA
SPRO	0.3	-0.06	0.67	-0.48	0.25	0.71	-0.08	0.14	0.73		SPRO
	BCYC	RLMD	RAPT	NAMS	BCAB	PASG	PMVP	IKNA	OLMA	SPRO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SPRO	+ 0.73	OLMA
SPRO	+ 0.71	PASG
PMVP	+ 0.68	NAMS
OLMA	+ 0.67	RAPT
SPRO	+ 0.67	RAPT
OLMA	+ 0.64	BCYC

High negative correlations

PASG	- 0.56	NAMS
SPRO	- 0.48	NAMS
OLMA	- 0.48	NAMS
PASG	- 0.25	RLMD
PMVP	- 0.24	PASG
OLMA	- 0.18	PMVP

Risk-Adjusted Indicators

There is a big difference between Fusion Stock performing well and Fusion Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fusion Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
BCYC	2.35	(0.28)	0.00	(0.05)	0.00	0.00	4.68	(3.70)	35.92
RLMD	2.67	(0.11)	(0.03)	0.02	2.92	(3.07)	7.47	(4.78)	21.75
RAPT	5.61	(0.82)	0.00	(1.06)	0.00	0.00	10.00	(11.56)	61.07
NAMS	2.32	0.11	0.07	0.17	3.32	(2.56)	5.33	(3.97)	29.23
BCAB	4.38	(0.30)	0.00	(0.07)	0.00	0.00	12.86	(7.59)	31.41
PASG	5.07	(0.24)	(0.01)	0.03	5.92	(5.86)	10.00	(9.88)	25.50
PMVP	1.61	0.03	(0.03)	0.25	2.00	(1.97)	3.75	(3.64)	13.98
IKNA	1.09	(0.01)	(0.07)	(0.16)	1.39	(1.50)	1.81	(1.74)	13.50
OLMA	2.89	(0.53)	0.00	(0.11)	0.00	0.00	6.17	(5.89)	19.19
SPRO	1.78	(0.31)	0.00	(0.58)	0.00	0.00	3.79	(4.58)	14.92

View Fusion Pharmaceuticals Related Equities

Bicycle Therapeutics Relmada Therapeutics RAPT Therapeutics NewAmsterdam Pharma Bioatla Passage Bio Pmv Pharmaceuticals Ikena Oncology Olema Pharmaceuticals Spero Therapeutics Bolt Biotherapeutics Coherus BioSciences Gracell Biotechnologies Neoleukin Therapeutics Keros Therapeutics

Risk & Return

Correlation

Fusion Pharmaceuticals Corporate Management

Christopher Leamon	Chief Officer	Profile
John Valliant	CEO Founder	Profile
Eric Hoffman	Senior Development	Profile
Dmitri MD	Chief Officer	Profile
Maria Stahl	Chief Officer	Profile
Victor Paulus	VP Affairs	Profile

Still Interested in Fusion Pharmaceuticals?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC